Costa-Tort Jesús, Schiavo-Di Flaviano Verónica, González-Navarro Beatriz, Jané-Salas Enric, Estrugo-Devesa Albert, López-López José
DDS, Master's student. School of Dentistry, University of Barcelona. University Campus of Bellvitge, Barcelona, Spain.
DDS, Master's degree. School of Dentistry, University of Barcelona. University Campus of Bellvitge, Barcelona, Spain.
J Clin Exp Dent. 2021 Sep 1;13(9):e948-e956. doi: 10.4317/jced.58586. eCollection 2021 Sep.
Oral antiplatelet and anticoagulant drugs are widely used in a large number of patients visiting the dentist, and there has been much controversy over the years towards their clinical management. The aim to carry out a literature review in order to develop an update on dental management in anticoagulated and / or anti aggregated patients, focusing on oral surgery.
A bibliographic search was carried out in PubMed on studies published between January 1, 2018, until December 10, 2020, using the keywords ("antiplatelet" OR "antiplatelets") AND ("dentistry"), and ("anticoagulant" OR "anticoagulants") AND ("dentistry").
The number of studies included in this review was 13, and the number of patients among all of them was 3.497 patients under treatment with some type of antithrombotic drug, who underwent different oral surgery treatments.
There is a low risk of peri- and postoperative bleeding events during basic oral surgery treatments in antiplatelet or anticoagulated patients, which can be easily managed through the use of local haemostatic measures. Oral surgery, antiplatelet drugs, anticoagulant drugs, dental treatment.
口服抗血小板和抗凝药物在大量看牙患者中广泛使用,多年来其临床管理一直存在诸多争议。目的是进行文献综述,以便更新对抗凝和/或抗聚集患者的牙科管理,重点是口腔外科手术。
在PubMed上对2018年1月1日至2020年12月10日期间发表的研究进行文献检索,使用关键词(“抗血小板”或“抗血小板药物”)和(“牙科”),以及(“抗凝剂”或“抗凝药物”)和(“牙科”)。
本综述纳入的研究数量为13项,所有研究中的患者数量为3497例接受某种抗血栓药物治疗并接受不同口腔外科手术治疗的患者。
抗血小板或抗凝患者在基本口腔外科手术治疗期间发生围手术期和术后出血事件的风险较低,通过使用局部止血措施可以轻松管理。口腔外科手术、抗血小板药物、抗凝药物、牙科治疗。